# Evolution of Coronary Stents: From Birth to Future Trends

**Authors:** Zhuo Huang, Charles Skarbek, Yulin Li, Joseph Touma, Pascal Desgranges, Romain Gallet, Jean Sénémaud

PMC · DOI: 10.3390/jcm15010047 · Journal of Clinical Medicine · 2025-12-21

## TL;DR

This paper reviews the development of coronary stents from their origins to modern innovations, highlighting how they have transformed heart disease treatment.

## Contribution

The paper provides a comprehensive historical and technological overview of coronary stents, emphasizing their evolution and future directions.

## Key findings

- Drug-eluting stents significantly reduced restenosis and repeat revascularization compared to earlier options.
- Biodegradable alloys and biomimetic coatings are emerging as key technologies in next-generation stent design.
- Challenges remain in achieving long-term stability and simplifying stent manufacturing for broader clinical use.

## Abstract

Coronary artery disease (CAD) remains one of the leading causes of mortality worldwide, affecting more than 300 million people. Over the past two decades, percutaneous coronary intervention (PCI) has become the cornerstone of CAD treatment, involving the implantation of coronary stents. This review clarifies how coronary stents emerged, evolved, and ultimately reshaped modern interventional cardiology. Beginning with balloon angioplasty and progressing through bare-metal and drug-eluting stents, we show how each advancement solved key clinical shortcomings—dramatically reducing restenosis, thrombosis, and repeat revascularization. We further review the major technological advances driving modern stent development, such as biodegradable alloys and biomimetic coatings. We also highlight the remaining challenges, including long-term stability, manufacturing complexity, and limited translational readiness. Together, these elements support our central thesis: that the historical evolution of coronary stents is fundamental to understanding present PCI practice and to guiding the next phase of device innovation.

## Linked entities

- **Diseases:** coronary artery disease (MONDO:0005010)

## Full-text entities

- **Diseases:** restenosis (MESH:D023903), thrombosis (MESH:D013927), CAD (MESH:D003324)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12786580/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12786580/full.md

## References

184 references — full list in the complete paper: https://tomesphere.com/paper/PMC12786580/full.md

---
Source: https://tomesphere.com/paper/PMC12786580